Last updated on June 2019

A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer


Brief description of study

The main purpose of this study is to examine the side effects that participants with metastatic breast cancer experience when taking abemaciclib with or without food.

Clinical Study Identifier: NCT03703466

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.